Related references
Note: Only part of the references are listed.What does plasma CRP tell us about peripheral and central inflammation in depression?
Jennifer C. Felger et al.
MOLECULAR PSYCHIATRY (2020)
The kynurenine pathway: a finger in every pie
Jonathan Savitz
MOLECULAR PSYCHIATRY (2020)
Meta-analysis of cytokine and C-reactive protein levels in high-risk psychosis
Sora Park et al.
SCHIZOPHRENIA RESEARCH (2020)
Pleiotropy and Specificity: Insights from the Interleukin 6 Family of Cytokines
Masaaki Murakami et al.
IMMUNITY (2019)
Can't or Won't? Immunometabolic Constraints on Dopaminergic Drive
Michael T. Treadway et al.
TRENDS IN COGNITIVE SCIENCES (2019)
Antipsychotics differentially regulate insulin, energy sensing, and inflammation pathways in hypothalamic rat neurons
Chantel Kowalchuk et al.
PSYCHONEUROENDOCRINOLOGY (2019)
Keeping up with the therapeutic advances in schizophrenia: a review of novel and emerging pharmacological entities
Amanda Krogmann et al.
CNS SPECTRUMS (2019)
An update on the efficacy of anti-inflammatory agents for patients with schizophrenia: a meta-analysis
N. Cakici et al.
PSYCHOLOGICAL MEDICINE (2019)
Association of baseline inflammatory markers and the development of negative symptoms in individuals at clinical high risk for psychosis
David R. Goldsmith et al.
BRAIN BEHAVIOR AND IMMUNITY (2019)
From cognitive and clinical substrates to functional profiles: Disentangling heterogeneity in schizophrenia
Marta Bosia et al.
PSYCHIATRY RESEARCH (2019)
Effortful Goal-Directed Behavior in Schizophrenia: Computational Subtypes and Associations With Cognition
Jessica A. Cooper et al.
JOURNAL OF ABNORMAL PSYCHOLOGY (2019)
Dopamine Transporter and Reward Anticipation in a Dimensional Perspective: A Multimodal Brain Imaging Study
Manon Dubol et al.
NEUROPSYCHOPHARMACOLOGY (2018)
A Randomized, Double-Blind, Placebo-Controlled Clinical Trial of Tocilizumab, An Interleukin-6 Receptor Antibody, For Residual Symptoms in Schizophrenia
Ragy R. Girgis et al.
NEUROPSYCHOPHARMACOLOGY (2018)
Meta-analysis of Cerebrospinal Fluid Cytokine and Tryptophan Catabolite Alterations in Psychiatric Patients: Comparisons Between Schizophrenia, Bipolar Disorder, and Depression
Alexandre K. Wang et al.
SCHIZOPHRENIA BULLETIN (2018)
Cannabidiol (CBD) as an Adjunctive Therapy in Schizophrenia: A Multicenter Randomized Controlled Trial
Philip McGuire et al.
AMERICAN JOURNAL OF PSYCHIATRY (2018)
Rethinking IL-6 and CRP: Why they are more than inflammatory biomarkers, and why it matters
Marco Del Giudice et al.
BRAIN BEHAVIOR AND IMMUNITY (2018)
Relation of inflammatory markers with symptoms of psychotic disorders: a large cohort study
E. J. Liemburg et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2018)
Differential neural reward mechanisms in treatment-responsive and treatment-resistant schizophrenia
Lucy D. Vanes et al.
PSYCHOLOGICAL MEDICINE (2018)
Inflammation in Schizophrenia: Pathogenetic Aspects and Therapeutic Considerations
Norbert Mueller
SCHIZOPHRENIA BULLETIN (2018)
Altered Serum Tumor Necrosis Factor and Interleukin-1β in First-Episode Drug-Naive and Chronic Schizophrenia
Furong Zhu et al.
FRONTIERS IN NEUROSCIENCE (2018)
Role of C-Reactive Protein at Sites of Inflammation and Infection
Nicola R. Sproston et al.
FRONTIERS IN IMMUNOLOGY (2018)
Cytokines in cerebrospinal fluid of patients with schizophrenia spectrum disorders: New data and an updated meta-analysis
Juan A. Gallego et al.
SCHIZOPHRENIA RESEARCH (2018)
Functional network dysconnectivity as a biomarker of treatment resistance in schizophrenia
Carolyn B. McNabb et al.
SCHIZOPHRENIA RESEARCH (2018)
TNF-α and IL-6 are associated with the deficit syndrome and negative symptoms in patients with chronic schizophrenia
David R. Goldsmith et al.
SCHIZOPHRENIA RESEARCH (2018)
Increased inflammation and brain glutamate define a subtype of depression with decreased regional homogeneity, impaired network integrity, and anhedonia
Ebrahim Haroon et al.
TRANSLATIONAL PSYCHIATRY (2018)
Disease Severity in Treatment Resistant Schizophrenia Patients Is Mainly Affected by Negative Symptoms, Which Mediate the Effects of Cognitive Dysfunctions and Neurological Soft Signs
Felice Iasevoli et al.
FRONTIERS IN PSYCHIATRY (2018)
The benefit of minocycline on negative symptoms of schizophrenia in patients with recent-onset psychosis (BeneMin): a randomised, double-blind, placebo-controlled trial
Bill Deakin et al.
LANCET PSYCHIATRY (2018)
Negative symptoms of schizophrenia: new developments and unanswered research questions
Silvana Galderisi et al.
LANCET PSYCHIATRY (2018)
C-Reactive Protein Correlates with Negative Symptoms in Patients with Schizophrenia
Ted Boozalis et al.
FRONTIERS IN PUBLIC HEALTH (2018)
Presynaptic Dopamine Capacity in Patients with Treatment-Resistant Schizophrenia Taking Clozapine: An [18F]DOPA PET Study
Euitae Kim et al.
NEUROPSYCHOPHARMACOLOGY (2017)
Lipopolysaccharide Alters Motivated Behavior in a Monetary Reward Task: a Randomized Trial
Julie Lasselin et al.
NEUROPSYCHOPHARMACOLOGY (2017)
Therapeutic Implications of Brain-Immune Interactions: Treatment in Translation
Andrew H. Miller et al.
NEUROPSYCHOPHARMACOLOGY (2017)
Towards an Immunophenotype of Schizophrenia: Progress, Potential Mechanisms, and Future Directions
Brian J. Miller et al.
NEUROPSYCHOPHARMACOLOGY (2017)
Inflammation Effects on Motivation and Motor Activity: Role of Dopamine
Jennifer C. Felger et al.
NEUROPSYCHOPHARMACOLOGY (2017)
Inflammation, Glutamate, and Glia: A Trio of Trouble in Mood Disorders
Ebrahim Haroon et al.
NEUROPSYCHOPHARMACOLOGY (2017)
Adjunctive minocycline for schizophrenia: A meta-analysis of randomized controlled trials
Ying-Qiang Xiang et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2017)
Effort-Based Reinforcement Processing and Functional Connectivity Underlying Amotivation in Medicated Patients with Depression and Schizophrenia
Il Ho Park et al.
JOURNAL OF NEUROSCIENCE (2017)
Adjunctive celecoxib for schizophrenia: A meta-analysis of randomized, double-blind, placebo-controlled trials
Wei Zheng et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2017)
The role of IL-6 in host defence against infections: immunobiology and clinical implications
Stefan Rose-John et al.
NATURE REVIEWS RHEUMATOLOGY (2017)
Presynaptic Dopamine Synthesis Capacity in Schizophrenia and Striatal Blood Flow Change During Antipsychotic Treatment and Medication-Free Conditions
Daniel Paul Eisenberg et al.
NEUROPSYCHOPHARMACOLOGY (2017)
Can C-reactive protein inform antidepressant medication selection in depressed outpatients? Findings from the CO-MED trial
Manish K. Jha et al.
PSYCHONEUROENDOCRINOLOGY (2017)
Kynurenic Acid in Schizophrenia: A Systematic Review and Meta-analysis
Eric Plitman et al.
SCHIZOPHRENIA BULLETIN (2017)
Primary, Enduring Negative Symptoms: An Update on Research
Brian Kirkpatrick et al.
SCHIZOPHRENIA BULLETIN (2017)
Impaired Glucose Homeostasis in First-Episode Schizophrenia A Systematic Review and Meta-analysis
Toby Pillinger et al.
JAMA PSYCHIATRY (2017)
C-reactive protein is increased in schizophrenia but is not altered by antipsychotics: meta-analysis and implications
B. S. Fernandes et al.
MOLECULAR PSYCHIATRY (2016)
Inflammation is associated with decreased functional connectivity within corticostriatal reward circuitry in depression
J. C. Felger et al.
MOLECULAR PSYCHIATRY (2016)
Inflammation as a predictive biomarker for response to omega-3 fatty acids in major depressive disorder: a proof-of-concept study
M. H. Rapaport et al.
MOLECULAR PSYCHIATRY (2016)
Abnormal Frontostriatal Activity During Unexpected Reward Receipt in Depression and Schizophrenia: Relationship to Anhedonia
Nuria Segarra et al.
NEUROPSYCHOPHARMACOLOGY (2016)
Treatment-Resistant Schizophrenia Patients Show Elevated Anterior Cingulate Cortex Glutamate Compared to Treatment-Responsive
Elias Mouchlianitis et al.
SCHIZOPHRENIA BULLETIN (2016)
A Neurocomputational Account of How Inflammation Enhances Sensitivity to Punishments Versus Rewards
Neil A. Harrison et al.
BIOLOGICAL PSYCHIATRY (2016)
Negative symptoms and their association with depressive symptoms in the long-term course of schizophrenia
Wolfram an der Heiden et al.
EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE (2016)
A meta-analysis of blood cytokine network alterations in psychiatric patients: comparisons between schizophrenia, bipolar disorder and depression
D. R. Goldsmith et al.
MOLECULAR PSYCHIATRY (2016)
Schizophrenia risk from complex variation of complement component 4
Aswin Sekar et al.
NATURE (2016)
Defeatist Performance Beliefs, Negative Symptoms, and Functional Outcome in Schizophrenia: A Meta-analytic Review
Timothy R. Campellone et al.
SCHIZOPHRENIA BULLETIN (2016)
Avolition in schizophrenia is associated with reduced willingness to expend effort for reward on a Progressive Ratio task
Gregory P. Strauss et al.
SCHIZOPHRENIA RESEARCH (2016)
An emerging role of cGMP in the treatment of schizophrenia: A review
Seong Shim et al.
SCHIZOPHRENIA RESEARCH (2016)
Inefficient effort allocation and negative symptoms in individuals with schizophrenia
Julie M. McCarthy et al.
SCHIZOPHRENIA RESEARCH (2016)
The role of inflammation in depression: from evolutionary imperative to modern treatment target
Andrew H. Miller et al.
NATURE REVIEWS IMMUNOLOGY (2016)
A guide to immunometabolism for immunologists
Luke A. J. O'Neill et al.
NATURE REVIEWS IMMUNOLOGY (2016)
Subtyping schizophrenia: A comparison of positive/negative and system-specific approaches
F. U. Lang et al.
COMPREHENSIVE PSYCHIATRY (2015)
Glutamate and dopamine in schizophrenia: An update for the 21st century
Oliver Howes et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2015)
Muscarinic regulation of dopamine and glutamate transmission in the nucleus accumbens
Jung Hoon Shin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Increased Interleukin-17 and decreased BAFF serum levels in drug-free acute schizophrenia
Yousri El Kissi et al.
PSYCHIATRY RESEARCH (2015)
The Right Stuff Revisited: What Have We Learned About the Determinants of Daily Functioning in Schizophrenia?
Michael F. Green et al.
SCHIZOPHRENIA BULLETIN (2015)
Effort-Based Decision-Making Paradigms for Clinical Trials in Schizophrenia: Part 2-External Validity and Correlates
William P. Horan et al.
SCHIZOPHRENIA BULLETIN (2015)
Effort-Based Decision-Making Paradigms for Clinical Trials in Schizophrenia: Part 1-Psychometric Characteristics of 5 Paradigms
L. Felice Reddy et al.
SCHIZOPHRENIA BULLETIN (2015)
Effort-based decision making as an objective paradigm for the assessment of motivational deficits in schizophrenia
Gagan Fervaha et al.
SCHIZOPHRENIA RESEARCH (2015)
Anhedonia in schizophrenia: Deficits in both motivation and hedonic capacity
Jiao Wang et al.
SCHIZOPHRENIA RESEARCH (2015)
Impaired effort allocation in patients with schizophrenia
Michael T. Treadway et al.
SCHIZOPHRENIA RESEARCH (2015)
High predictive value of immune-inflammatory biomarkers for schizophrenia diagnosis and association with treatment resistance
Cristiano Noto et al.
WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY (2015)
Effort discounting and its association with negative symptoms in schizophrenia
Lise Docx et al.
COGNITIVE NEUROPSYCHIATRY (2015)
Are Anti-inflammatory Therapies Viable Treatments for Psychiatric Disorders? Where the Rubber Meets the Road
Andrew H. Miller et al.
JAMA PSYCHIATRY (2015)
Dissecting negative symptoms in schizophrenia: Opportunities for translation into new treatments
George Foussias et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2015)
Genetic pleiotropy between multiple sclerosis and schizophrenia but not bipolar disorder: differential involvement of immune-related gene loci
O. A. Andreassen et al.
MOLECULAR PSYCHIATRY (2015)
Apathy But Not Diminished Expression in Schizophrenia Is Associated With Discounting of Monetary Rewards by Physical Effort
Matthias N. Hartmann et al.
SCHIZOPHRENIA BULLETIN (2015)
Deficit schizophrenia: an update
BRIAN KIRKPATRICK et al.
World Psychiatry (2015)
Contribution of substantia nigra glutamate to prediction error signals in schizophrenia: a combined magnetic resonance spectroscopy/functional imaging study
David M. White et al.
NPJ SCHIZOPHRENIA (2015)
Motivational and neurocognitive deficits are central to the prediction of longitudinal functional outcome in schizophrenia
G. Fervaha et al.
ACTA PSYCHIATRICA SCANDINAVICA (2014)
Excess Early Mortality in Schizophrenia
Thomas Munk Laursen et al.
ANNUAL REVIEW OF CLINICAL PSYCHOLOGY, VOL 10 (2014)
Thinking and acting beyond the positive: the role of the cognitive and negative symptoms in schizophrenia
Maren Carbon et al.
CNS SPECTRUMS (2014)
Interleukin-6 and its receptors: A highly regulated and dynamic system
Janina Wolf et al.
CYTOKINE (2014)
Psychopharmacology of the negative symptoms: Current status and prospects for progress
Michael C. Davis et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2014)
The social and economic burden of treatment-resistant schizophrenia: a systematic literature review
James L. Kennedy et al.
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY (2014)
Biological insights from 108 schizophrenia-associated genetic loci
Stephan Ripke et al.
NATURE (2014)
Lipopolysaccharide Reduces Incentive Motivation While Boosting Preference for High Reward in Mice
Elisabeth G. Vichaya et al.
NEUROPSYCHOPHARMACOLOGY (2014)
Peripheral interleukin-2 level is associated with negative symptoms and cognitive performance in schizophrenia
Elson Asevedo et al.
PHYSIOLOGY & BEHAVIOR (2014)
Individual differences in the peripheral immune system promote resilience versus susceptibility to social stress
Georgia E. Hodes et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Increased serum interleukin-6 levels in early stages of psychosis: Associations with at-risk mental states and the severity of psychotic symptoms
Alexander Stojanovic et al.
PSYCHONEUROENDOCRINOLOGY (2014)
A Review of Reward Processing and Motivational Impairment in Schizophrenia
Gregory P. Strauss et al.
SCHIZOPHRENIA BULLETIN (2014)
Amotivation in Schizophrenia: Integrated Assessment With Behavioral, Clinical, and Imaging Measures
Daniel H. Wolf et al.
SCHIZOPHRENIA BULLETIN (2014)
Reliability and validity of the Calgary Depression Scale for Schizophrenia (CDSS) in youth at clinical high risk for psychosis
Jean Addington et al.
SCHIZOPHRENIA RESEARCH (2014)
Cytokine function in medication-naive first episode psychosis: A systematic review and meta-analysis
Rachel Upthegrove et al.
SCHIZOPHRENIA RESEARCH (2014)
Decreased interleukin-10 serum levels in first-episode drug-naive schizophrenia: Relationship to psychopathology
Mei Hong Xiu et al.
SCHIZOPHRENIA RESEARCH (2014)
Effort, Anhedonia, and Function in Schizophrenia: Reduced Effort Allocation Predicts Amotivation and Functional Impairment
Deanna M. Barch et al.
JOURNAL OF ABNORMAL PSYCHOLOGY (2014)
Clinical Phenotypes of Psychosis in the Bipolar-Schizophrenia Network on Intermediate Phenotypes (B-SNIP)
Carol A. Tamminga et al.
AMERICAN JOURNAL OF PSYCHIATRY (2013)
The Clinical Assessment Interview for Negative Symptoms (CAINS): Final Development and Validation
Ann M. Kring et al.
AMERICAN JOURNAL OF PSYCHIATRY (2013)
Negative Symptoms of Schizophrenia Are Associated with Abnormal Effort-Cost Computations
James M. Gold et al.
BIOLOGICAL PSYCHIATRY (2013)
The Motivation and Pleasure Scale-Self-Report (MAP-SR): Reliability and validity of a self-report measure of negative symptoms
Katiah Llerena et al.
COMPREHENSIVE PSYCHIATRY (2013)
Deconstructing negative symptoms of schizophrenia: Avolition-apathy and diminished expression clusters predict clinical presentation and functional outcome
Gregory P. Strauss et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2013)
Incentive motivation deficits in schizophrenia reflect effort computation impairments during cost-benefit decision-making
Gagan Fervaha et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2013)
A new perspective for schizophrenia: TAAR1 agonists reveal antipsychotic- and antidepressant-like activity, improve cognition and control body weight
F. G. Revel et al.
MOLECULAR PSYCHIATRY (2013)
The brain reward circuitry in mood disorders
Scott J. Russo et al.
NATURE REVIEWS NEUROSCIENCE (2013)
Prenatal maternal infection, neurodevelopment and adult schizophrenia: a systematic review of population-based studies
G. M. Khandaker et al.
PSYCHOLOGICAL MEDICINE (2013)
Adjunctive Use of Nonsteroidal Anti-inflammatory Drugs for Schizophrenia: A Meta-analytic Investigation of Randomized Controlled Trials
Masahiro Nitta et al.
SCHIZOPHRENIA BULLETIN (2013)
Assessment of everyday functioning in schizophrenia: Implications for treatments aimed at negative symptoms
Philip D. Harvey
SCHIZOPHRENIA RESEARCH (2013)
A Randomized Controlled Trial of the Tumor Necrosis Factor Antagonist Infliximab for Treatment-Resistant Depression
Charles L. Raison et al.
JAMA PSYCHIATRY (2013)
Parsing Anhedonia: Translational Models of Reward-Processing Deficits in Psychopathology
Michael T. Treadway et al.
CURRENT DIRECTIONS IN PSYCHOLOGICAL SCIENCE (2013)
Dopamine Synthesis Capacity in Patients With Treatment-Resistant Schizophrenia
Arsime Demjaha et al.
AMERICAN JOURNAL OF PSYCHIATRY (2012)
Dopaminergic Mechanisms of Reduced Basal Ganglia Responses to Hedonic Reward During Interferon Alfa Administration
Lucile Capuron et al.
ARCHIVES OF GENERAL PSYCHIATRY (2012)
Alterations of the Brain Reward System in Antipsychotic Naive Schizophrenia Patients
Mette Odegaard Nielsen et al.
BIOLOGICAL PSYCHIATRY (2012)
Cytokine effects on the basal ganglia and dopamine function: The subcortical source of inflammatory malaise
Jennifer C. Felger et al.
FRONTIERS IN NEUROENDOCRINOLOGY (2012)
Nonsteroidal Anti-Inflammatory Drugs in Schizophrenia: Ready for Practice or a Good Start? A Meta-Analysis
Iris E. Sommer et al.
JOURNAL OF CLINICAL PSYCHIATRY (2012)
Disambiguating ventral striatum fMRI-related bold signal during reward prediction in schizophrenia
R. W. Morris et al.
MOLECULAR PSYCHIATRY (2012)
Ventral Striatal Activation during Reward Processing in Subjects with Ultra-High Risk for Schizophrenia
Georg Juckel et al.
NEUROPSYCHOBIOLOGY (2012)
From Revolution to Evolution: The Glutamate Hypothesis of Schizophrenia and its Implication for Treatment
Bita Moghaddam et al.
NEUROPSYCHOPHARMACOLOGY (2012)
Defining treatment-resistant schizophrenia and response to antipsychotics: A review and recommendation
Takefumi Suzuki et al.
PSYCHIATRY RESEARCH (2012)
Inflammatory markers in antipsychotic-naive patients with nonaffective psychosis and deficit vs. nondeficit features
Clemente Garcia-Rizo et al.
PSYCHIATRY RESEARCH (2012)
NMDA Receptor Hypofunction, Parvalbumin-Positive Neurons, and Cortical Gamma Oscillations in Schizophrenia
Guillermo Gonzalez-Burgos et al.
SCHIZOPHRENIA BULLETIN (2012)
Childhood infection and adult schizophrenia: A meta-analysis of population-based studies
Golam M. Khandaker et al.
SCHIZOPHRENIA RESEARCH (2012)
Factor structure of the brief negative symptom scale
Gregory P. Strauss et al.
SCHIZOPHRENIA RESEARCH (2012)
Homelessness in Schizophrenia
Adriana Foster et al.
PSYCHIATRIC CLINICS OF NORTH AMERICA (2012)
Autoimmune Diseases and Severe Infections as Risk Factors for Schizophrenia: A 30-Year Population-Based Register Study
Michael E. Benros et al.
AMERICAN JOURNAL OF PSYCHIATRY (2011)
The pro- and anti-inflammatory properties of the cytokine interleukin-6
Juergen Scheller et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2011)
Meta-Analysis of Cytokine Alterations in Schizophrenia: Clinical Status and Antipsychotic Effects
Brian J. Miller et al.
BIOLOGICAL PSYCHIATRY (2011)
The Brief Negative Symptom Scale: Psychometric Properties
Brian Kirkpatrick et al.
SCHIZOPHRENIA BULLETIN (2011)
Development and psychometric validation of the Clinical Assessment Interview for Negative Symptoms (CAINS)
William P. Horan et al.
SCHIZOPHRENIA RESEARCH (2011)
Large-scale brain networks and psychopathology: a unifying triple network model
Vinod Menon
TRENDS IN COGNITIVE SCIENCES (2011)
Prenatal Infection and Schizophrenia: A Review of Epidemiologic and Translational Studies
Alan S. Brown et al.
AMERICAN JOURNAL OF PSYCHIATRY (2010)
Research Domain Criteria (RDoC): Toward a New Classification Framework for Research on Mental Disorders
Thomas Insel et al.
AMERICAN JOURNAL OF PSYCHIATRY (2010)
Inflammation-Induced Anhedonia: Endotoxin Reduces Ventral Striatum Responses to Reward
Naomi I. Eisenberger et al.
BIOLOGICAL PSYCHIATRY (2010)
Prevalence of Negative Symptoms in Outpatients With Schizophrenia Spectrum Disorders Treated With Antipsychotics in Routine Clinical Practice: Findings From the CLAMORS Study
Julio Bobes et al.
JOURNAL OF CLINICAL PSYCHIATRY (2010)
Functional Connectivity and Brain Networks in Schizophrenia
Mary-Ellen Lynall et al.
JOURNAL OF NEUROSCIENCE (2010)
Periods of Recovery in Deficit Syndrome Schizophrenia: A 20-Year Multi-follow-up Longitudinal Study
Gregory P. Strauss et al.
SCHIZOPHRENIA BULLETIN (2010)
Celecoxib treatment in an early stage of schizophrenia: Results of a randomized, double-blind, placebo-controlled trial of celecoxib augmentation of amisulpride treatment
Norbert Mueller et al.
SCHIZOPHRENIA RESEARCH (2010)
Neural Origins of Human Sickness in Interoceptive Responses to Inflammation
Neil A. Harrison et al.
BIOLOGICAL PSYCHIATRY (2009)
Reward Feedback Alterations in Unmedicated Schizophrenia Patients: Relevance for Delusions
Florian Schlagenhauf et al.
BIOLOGICAL PSYCHIATRY (2009)
Persistently increased serum soluble interleukin-2 receptors in continuously ill patients with schizophrenia
Catherine Bresee et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2009)
Neural Correlates of Probabilistic Category Learning in Patients with Schizophrenia
Thomas W. Weickert et al.
JOURNAL OF NEUROSCIENCE (2009)
Cerebral Microglia Recruit Monocytes into the Brain in Response to Tumor Necrosis Factorα Signaling during Peripheral Organ Inflammation
Charlotte D'Mello et al.
JOURNAL OF NEUROSCIENCE (2009)
Common variants on chromosome 6p22.1 are associated with schizophrenia
Jianxin Shi et al.
NATURE (2009)
Worth the 'EEfRT'? The Effort Expenditure for Rewards Task as an Objective Measure of Motivation and Anhedonia
Michael T. Treadway et al.
PLOS ONE (2009)
The Dopamine Hypothesis of Schizophrenia: Version III - The Final Common Pathway
Oliver D. Howes et al.
SCHIZOPHRENIA BULLETIN (2009)
Dysconnection in Schizophrenia: From Abnormal Synaptic Plasticity to Failures of Self-monitoring
Klaas E. Stephan et al.
SCHIZOPHRENIA BULLETIN (2009)
Determinants of everyday outcomes in schizophrenia: The influences of cognitive impairment, functional capacity, and symptoms
Feea R. Leifker et al.
SCHIZOPHRENIA RESEARCH (2009)
Peripheral inflammation is associated with altered substantia nigra activity and psychomotor slowing in humans
Lena Bryclon et al.
BIOLOGICAL PSYCHIATRY (2008)
Chronic immune stimulation correlates with reduced phenylalanine turnover
G. Neurauter et al.
CURRENT DRUG METABOLISM (2008)
Substantia nigra/ventral tegmental reward prediction error disruption in psychosis
G. K. Murray et al.
MOLECULAR PSYCHIATRY (2008)
Effects of interferon-alpha on rhesus monkeys: A nonhuman primate model of cytokine-induced depression
Jennifer C. Felger et al.
BIOLOGICAL PSYCHIATRY (2007)
Selective reinforcement learning deficits in schizophrenia support predictions from computational models of striatal-cortical dysfunction
James A. Waltz et al.
BIOLOGICAL PSYCHIATRY (2007)
Brain-immune communication pathways
Ning Quan et al.
BRAIN BEHAVIOR AND IMMUNITY (2007)
Outcomes of public concern in schizophrenia
Iain Kooyman et al.
BRITISH JOURNAL OF PSYCHIATRY (2007)
Elevated serum levels of C-reactive protein are associated with more severe psychopathology in a subgroup of patients with schizophrenia
Xiaoduo Fan et al.
PSYCHIATRY RESEARCH (2007)
Effort-related functions of nucleus accumbens dopamine and associated forebrain circuits
J. D. Salamone et al.
PSYCHOPHARMACOLOGY (2007)
Deficit in schizophrenia to recruit the striatum in implicit learning: A functional magnetic resonance imaging investigation
Jeffrey P. Reiss et al.
SCHIZOPHRENIA RESEARCH (2006)
Dysfunction of ventral striatal reward prediction in schizophrenic patients treated with typical, not atypical, neuroleptics
Georg Juckel et al.
PSYCHOPHARMACOLOGY (2006)
The structure of negative symptoms within schizophrenia: Implications for assessment
JJ Blanchard et al.
SCHIZOPHRENIA BULLETIN (2006)
The NIMH-MATRICS consensus statement on negative symptoms
B Kirkpatrick et al.
SCHIZOPHRENIA BULLETIN (2006)
Association of schizophrenia and autoimmune diseases: Linkage of Danish National Registers
WW Eaton et al.
AMERICAN JOURNAL OF PSYCHIATRY (2006)
Dysfunction of ventral striatal reward prediction in schizophrenia
G Juckel et al.
NEUROIMAGE (2006)
The economic burden of schizophrenia in Canada in 2004
R Goeree et al.
CURRENT MEDICAL RESEARCH AND OPINION (2005)
C-reactive protein: Ligands, receptors and role in inflammation
L Marnell et al.
CLINICAL IMMUNOLOGY (2005)
Celecoxib augmentation of continuously Ill patients with schizophrenia
MH Rapaport et al.
BIOLOGICAL PSYCHIATRY (2005)
Neuroprotection by tetracyclines
M Domercq et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2004)
The neural substrates of reward processing in humans: The modern role of fMRI
SM Mcclure et al.
NEUROSCIENTIST (2004)
Schizophrenia and employment - A review
S Marwaha et al.
SOCIAL PSYCHIATRY AND PSYCHIATRIC EPIDEMIOLOGY (2004)
Markers of inflammation and cardiovascular disease application to clinical and public health practice - A statement for healthcare professionals from the centers for disease control and prevention and the American Heart Association
TA Pearson et al.
CIRCULATION (2003)
Brain reward circuitry: Insights from unsensed incentives
RA Wise
NEURON (2002)
Beneficial antipsychotic effects of celecoxib add-on therapy compared to risperidone alone in schizophrenia
N Müller et al.
AMERICAN JOURNAL OF PSYCHIATRY (2002)
A separate disease within the syndrome of schizophrenia
B Kirkpatrick et al.
ARCHIVES OF GENERAL PSYCHIATRY (2001)
Vagal immune-to-brain communication: a visceral chemosensory pathway
LE Goehler et al.
AUTONOMIC NEUROSCIENCE-BASIC & CLINICAL (2000)
Share Paper
